Issi Rozen

Cambridge, Massachusetts, United States

Bio

Professional summary

Issi Rozen is a general partner at GV focused on company formation and early-stage life sciences investments. He is a biotech executive and serial entrepreneur who co-founded multiple startups, including Verve Therapeutics. Before GV, he was Chief Business Officer at the Broad Institute of MIT and Harvard, where he led strategic alliances, partnering, licensing, and new-venture creation.

Notable companies

Selected portfolio companies the partner has backed

Aera TherapeuticsEveryONE MedicinesMestag TherapeuticsMonte Rosa TherapeuticsVerve Therapeutics

Background

Career, education, and skills

Career history

GVGeneral PartnerPresent
Broad Institute of MIT and HarvardChief Business Officer
Berklee College of MusicProfessor

Education

MIT Sloan School of ManagementMBA

Other partners at Google Ventures

12 more profiles

View firm →

Anika Gupta Vatsa, PhD

Principal

Google Ventures

GV principal investing in biotech companies developing new medicines.

BiotechGenomicsGrowth stageLife sciencesNew medicinesSeed stage

Anthony Philippakis

General Partner

Google Ventures

Anthony Philippakis is a General Partner at GV investing at the intersection of life sciences and machine learning. He is a physician, genomicist, and data scientist with prior cardiology training at Brigham and Women's Hospital.

GenomicsHealthcareLife sciences

Ben Robbins

General Partner

Google Ventures

GV general partner investing in healthcare delivery and neuropsychiatric therapeutics.

Digital healthHealthcare deliveryHealthcare servicesMental healthNeuropsychiatric therapeutics

Brendan Bulik-Sullivan

General Partner

Google Ventures

GV life sciences general partner with a statistical genetics and ML background.

BiotechDiagnosticsLife sciencesMachine learningStatistical geneticsTherapeutics

Crystal Huang

General Partner

Google Ventures

Crystal Huang is a general partner at GV focused on SaaS, infrastructure, and AI. She has a particular interest in product-led and developer-led adoption strategies.

AI applicationsEnterprise software

Dave Munichiello

Managing Partner

Google Ventures

Dave Munichiello is a Managing Partner at GV leading the firm's tech investing team across consumer, enterprise, and frontier areas.

AIConsumerEnterpriseFrontier TechGrowthSeed / Early Stage

David Krane

CEO & Managing Partner

Google Ventures

David Krane is CEO and Managing Partner at GV, where he leads global activities and invests in consumer-focused companies.

ConsumerCross-stage

David Schenkein, MD

General Partner

Google Ventures

GV life sciences general partner and physician-investor focused on therapeutics and healthcare innovation.

Care deliveryDiagnosticsLife sciencesMedical devicesPayer innovationTherapeutics

Elena Sakach

Partner

Google Ventures

GV partner investing across fintech, software, and AI from the San Francisco office.

Artificial intelligenceFintechGrowth investingPublic marketsSoftware

Erik Nordlander

General Partner

Google Ventures

Erik Nordlander is a general partner at GV investing in enterprise software and frontier technology. His focus areas include developer tools, cloud infrastructure, and machine learning.

AIEnterprise software

Frederique Dame

General Partner

Google Ventures

General Partner at GV investing across consumer, AI, life sciences, and women’s health after product leadership roles at Uber and Yahoo.

AIConsumerGrowthLife SciencesSeed / Early StageWomen's health

Karim Faris

General Partner

Google Ventures

Karim Faris is a GV general partner investing in enterprise software, analytics, AI, and security. He has been with GV since its inception.

AI/ML infrastructureCybersecurityEnterprise software

See something out of date?

Suggest a correction — our team reviews every edit.

Improve this profile